Delivery Order SPE2DB20D1100-SPE2DB25FD8Y2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $27,094.95 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count packages) on August 25, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026. The...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Voranigo 40 mg tablets in a quantity of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $54,189.90 and employs firm fixed pricing, with an ultimate completion date of September 16, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and...
- The Defense Logistics Agency awarded a $27,094.95 delivery order to AmerisourceBergen Drug Corp for Voranigo 40 mg tablets (30-count units) on August 11, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price, non-set-aside contract is performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $76,246.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Voranigo 10 mg tablets (30-count packages). The contract, which is non-set-aside and competitively awarded, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 14, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $54,419.24 delivery order to AmerisourceBergen Drug Corp for the supply of Voranigo 10 mg tablets (30-count units) under a firm fixed-price contract. The award, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a non-competitive, competitively awarded transaction executed without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- This federal contract award, valued at $27,094.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the provision of 4,568,061,524 units of Voranigo 40 mg tablets, with a completion date of May 19, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, with no...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,094.95 firm fixed-price delivery order contract is for the supply of "VORANIGO 40 MG TABLET 30S", a pharmaceutical product. The contract has an ultimate completion date of July 29, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,385.52 by the Defense Logistics Agency (DLA) on July 25, 2025, with an ultimate completion date of August 15, 2025. The contract, issued under firm fixed-price terms with no set-aside designation, covers the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This delivery order represents a child contract under AmerisourceBergen's broader...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $41,791.72 on August 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price contract, which is not set-aside and was competitively awarded, is scheduled for ultimate completion on August 26, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $41,512.55 by the Defense Logistics Agency's Medical Supply Chain on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order represents a non-competitive award and will be performed at the vendor's Conshohocken facility. The award is issued as a child contract under AmerisourceBergen's larger...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD8Y2Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $54,189.90 for 30-count tablets of Voranigo 40 mg on August 6, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the distributor to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs globally. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company maintains an extensive portfolio of federal contract awards covering diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies. As a major healthcare solutions provider headquartered in Pennsylvania, AmerisourceBergen has demonstrated capability to meet competitive federal procurement requirements through its consistent delivery of medical commodities across multiple therapeutic domains and contract values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $54.2k | 8/6/25 |